The objectives of this proposal are to further preclinical development of unique two-photon-activated photodynamic therapy (TPPDT) triads that incorporate a nontoxic porphyrin photosensitizer, a tumor ...SBIR Phase II 2012 Department of Health and Human Services
The objectives are to further the pre-clinical development of unique two-photon activated Photodynamic Therapy (PTD) triads that incorporate a photosensitizer, a tumor receptor targeting group, and an ...SBIR Phase I 2010 Department of Health and Human Services
SENSOPATH TECHNOLOGIES, INC.
| 920 Technology Blvd
BOZEMAN, MT, 59718-4001
|Socially and Economically Disadvantaged:||N|
|Number of Employees:||6|